Recent Treatment Strategies for Polycystic Ovary Syndrome.
10.4093/jkd.2015.16.3.194
- Author:
Hyejin LEE
1
Author Information
1. Department of Internal Medicine, Ewha Womans University School of Medicine, Seoul, Korea. hyejinlee@ewha.ac.kr
- Publication Type:Review
- Keywords:
Androgen;
Management;
Polycystic ovary syndrome
- MeSH:
Clomiphene;
Contraceptive Agents;
Diabetes Mellitus, Type 2;
Female;
Humans;
Hyperandrogenism;
Infertility;
Metformin;
Ovary;
Phenotype;
Polycystic Ovary Syndrome*
- From:Journal of Korean Diabetes
2015;16(3):194-197
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in reproductive-aged women. This syndrome is characterized by its heterogeneous presentation including oligoovulation, hyperandrogenism and polycystic ovary morphology. Moreover, women with PCOS exhibit metabolic dysfunction and have an increased risk of type 2 diabetes mellitus. The treatment approach is dependent on the presenting phenotype. Hormonal contraceptives are the first-line management for menstrual abnormalities and androgen excess symptoms, whereas clomiphene is the first-line therapy for infertility. Metformin is beneficial for metabolic abnormalities and menstrual irregularities.
